Neuroendocrine Tumors Douglas G. Adler, MD Dr. Adler is an assistant professor of medicine and director of Therapeutic Endoscopy, University of Utah School of Medicine/Huntsman Cancer Center, Salt Lake City, UT. The questions below are based on the article “Neuroendocrine Tumors: Review and Clinical Update”. Choose the single best answer for each question.
	1. Which of the following is the most common neuroendocrine tumor encountered in clinical practice? Carcinoid tumor Gastrinoma Glucagonoma Insulinoma Vasoactive intestinal peptide-producing tumors (VIPoma) Click here to compare your answer. 2. In general, in a patient with a suspected neuroendocrine tumor, which imaging test should be obtained first? Abdominal ultrasound Computed tomography (CT) scan of the abdomen and pelvis Magnetic resonance imaging (MRI) of the abdomen and pelvis Positron emission tomography (PET) scan Somatostatin receptor scintigraphy (SRS) Click here to compare your answer. 3. A patient with recurrent bleeding gastric and duodenal ulcers despite the use of high-dose acid suppression therapy is found to have a pancreatic mass on CT. This lesion is most likely secreting which of the following substances? Gastrin Glucagon Insulin Thyroxine Vasoactive intestinal peptide Click here to compare your answer.		4. A 45-year-old woman has clinical signs and symptoms and laboratory findings consistent with the presence of a functioning carcinoid tumor. A CT scan of the patient’s abdomen and pelvis is unrevealing. Which of the following is the next best imaging test to identify the location of the primary lesion? Endoscopic ultrasound MRI of the abdomen and pelvis PET of the abdomen and pelvis Right upper quadrant ultrasound SRS Click here to compare your answer . 5. What percentage of patients with multiple endocrine neoplasia type 1 (MEN1) who undergo complete resection of neuroendocrine tumors will develop a recurrence within 10 years? 1% 10% 25% 50% 75% Click here to compare your answer. 6. MEN1 is most frequently associated with the development of which of the following enteropancreatic tumors? Gastrinoma Glucagonoma Insulinoma Somatostatinoma VIPoma Click here to compare your answer. 7. Which of the following is the drug of choice to control symptoms in most patients with neuroendocrine tumors? Acid suppression therapy Insulin Interferon Intravenous glucose Somatostatin analogues Click here to compare your answer.
	Click here to read more about Neuroendocrine Tumors (Requires Adobe Acrobat Reader) Check our archives to test your knowledge in other featured articles: If you do not already have Acrobat Reader, simply click on the icon below, scroll down to the "Get the Free Acrobat Reader" heading and follow the instructions to install the program. Acrobat enables you to convert any document into an Adobe Portable Document Format (PDF) file for easy viewing. Download Adobe Acrobat Reader
Hospital Physician     JCOM     Seminars in Medical Practice Hospital Physician Board Review Manuals About TWC    Subscribe    Contact TWC    Home    Search   Site Map Copyright © 2009, Turner White Communications Updated 1/04/08 • kkj